You just read:

Two Year Results of Phase 3 Studies with EYLEA™ (aflibercept) Injection in wet AMD Show Sustained Improvement in Visual Acuity

News provided by

Regeneron Pharmaceuticals, Inc.

Dec 05, 2011, 02:31 ET